4S. Claiborne Johnston,Mai N. Nguyen-Huynh,Miriam E. Schwarz,Kate Fuller,Christina Williams,S. Andrew Josephsort,Graeme J. Hankey,Robert G. Hart,Steven R. Levine,Jose Biller,Robert D. Brown,Ralph L. Sacco,L. Jaap Kappelle,Peter J. Koudstaal,Julien Bogousslavsky,Louis R. Caplan,Jan van Gijn,Ale Algra,Peter M. Rothwell,Harold P. Adams,Gregory W. Albers,李海峰（译）.美国国家卒中协会短暂性脑缺血发作处理指南[J].国际脑血管病杂志,2007,15(3):161-171. 被引量：5
5Libby P, Ridker PM, Maseri A. Inflammation and atherosis[J]. Circulation, 2002,105 ( 1 ): 1135 - 1143.
6Bustos C, Hernandez- Presa MA, Ortego M.et al. HMG- CoA reduc tase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis[J]. Am Coll Cardiol,1998,32:2057- 2064.
7Ridker PM, Rifai N, Clearfield M. el al. Measurement of C - reac rive protein for the targeting of statin therapy in the primary pre vention of acute coronary events[J].N Engl J Med, 2001,344 1959 - 1965.
8Herbert JM, Tissinier A, Defreyn G, et al. Inhibitory effect of clopidogrel on platelet adhesion and intinal proliferation after arterial injury in rabbits [ J ]. Arterioscler Thromb 1993,13 : 1171 - 1179.
9Charo IF, Taubman MB. Chemokines in the pathogenesis of vascular disease[J]. Circ Res, 2004,95:858 -866.
2Packard RR, Libby P. Inflammation in atherosclerosis: from vascular biology to biomarker discoveryand risk prediction[J]. Clin Chem,2008,54(1) :24 -38.
3Harm W, Anselm KG, Rudolf S. Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syn dromes taking atovasatin versus other stain therapies[J]. Am J Cardiol, 2003,92 (3): 285-288.
4Juan JB, Deepak LB,Jean-Marc H. Clinical evidence for anti-in flammatory effeets of anti-piatelet therapy in patients with atherothrombotic disease [J]. Vascularmedicine, 2007, 12 ( 2 ) : 113- 122.
